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Abstract
Atherosclerotic plaque formation is fueled by the persistence of lipid-laden macrophages in the
artery wall. The mechanisms by which these cells become trapped, thereby establishing chronic
inflammation, remain unknown. Netrin-1, a neuroimmune guidance cue, was secreted by
macrophages in human and mouse atheroma, where it inactivated macrophage migration to
chemokines implicated in their egress from plaques. Acting via its receptor UNC5b, netrin-1
inhibited CCL2- and CCL19-directed macrophage migration, Rac1 activation and actin
polymerization. Targeted deletion of netrin-1 in macrophagesseverely diminished atherosclerosis
progression in Ldlr−/− mice and promoted macrophage emigration from plaques. Thus, netrin-1
promotes atherosclerosis by retaining macrophages in the artery wall and establish a causative role
for negative regulators of leukocyte migration in chronic inflammation.
Atherosclerosis is a disease of chronic inflammation that is distinguished by the persistence
of cholesterol-engorged macrophages in arterial plaques. Arterial inflammation is initiated
by the subendothelial retention of plasma low density lipoprotein (LDL), and enhanced by
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oxidative modification of these lipoproteins, which triggers an influx of monocytes1. Unlike
other inflammatory states, atherosclerotic inflammation does not readily resolve and
cholesterol-laden macrophages persist in the arterial wall. These macrophage “foam cells”
cause expansion of the plaque though recruitment of additional leukocytes and vascular
smooth muscle cells, and contribute prominently to plaque instability through the secretion
of extracellular matrix-degrading proteases and cytotoxic factors. Notably, atherosclerotic
plaques that cause clinical events (ie. myocardial infarction and stroke) are characterized by
a high macrophage content2.
While macrophage retention in the artery wall has long been recognized as a fundamental
step in creating the chronic inflammatory milieu underlying atherosclerosis, the mechanisms
regulating this process are not well understood. Resolution of acute inflammation typically
involves emigration of monocyte-derived cells out of the inflamed site through nearby
lymphatic vessels3. This process appears to be impaired in atherosclerosis and has been
attributed, in part, to the cholesterol loading of macrophages which shifts these cells to a
more sessile phenotype4. Recent studies in transplant-based mouse models of atherosclerosis
regression have shown that reducing plasma non-HDL cholesterol and/or increasing high-
density lipoproteins (HDL), promotes emigration of macrophages from lesions to regional
and systemic lymph nodes5-9. Macrophage expression of the chemokine receptor CCR7 was
shown to be essential for decreasing the macrophage content of plaques8,9, implicating the
CCR7-specific ligands CCL19 and CCL21 in promoting the egress of these cells from the
artery wall. These studies indicate that macrophage emigration from the plaque is actively
inhibited during hypercholesterolemia, although the regulatory signals that impair this
process remain largely unknown.
A paradigm for inhibitory guidance cues exists in the developing nervous system, where
axonal migration relies on the integration of both chemorepulsive and chemoattractive
signals to steer the axonal growth cone. One such guidance molecule netrin-1, a secreted
laminin-related molecule, mediates both chemorepulsion and chemoattraction of axons
navigating the spinal cord midline. This context-dependent response to netrin-1 is regulated
by differential receptor expression by the target cell. For example, neurons expressing the
Deleted in Colon Cancer (DCC) receptor or Neogenin are attracted by a diffusible gradient
of netrin-1 secreted at the midline10. Conversely, co-expression of the UNC5b receptor with
DCC converts netrin-1 attraction to repulsion, whereas expression of UNC5b alone mediates
short-range repulsion10,11. Previous studies have uncovered instructional roles for netrin-1
and its receptors outside the nervous system in organogenesis12,13, angiogenesis14,15 and
tumorigenesis16,17, suggesting that netrin-1 regulates cell migration in a broader context.
Work from our group identified netrin-1 as a leukocyte guidance cue expressed by the
endothelium that is downregulated during acute infection with Staphylococcus aureus18.
These studies established that netrin-1 inhibited migration of monocytes, neutrophils and
lymphocytes via its receptor UNC5b. Recent studies in models of hypoxia and reperfusion
injury have extended these findings to show that expression of netrin-1 by epithelial cells
also attenuates leukocyte accumulation18-21. Given its role in inhibiting leukocyte migration,
we sought to determine whether netrin-1 contributed to the retention of macrophages in the
chronic inflammatory milieu of the atherosclerotic plaque. Our studies show that netrin-1
was abundantly expressed by macrophage foam cells formed in vitro and in vivo, and in
atherosclerotic lesions. In functional studies we demonstrate that netrin-1 expressed by foam
cells differentially regulated the cellular constituents of atheroma. Netrin-1 inactivated
macrophage migration and supported chemoattraction of coronary artery smooth muscle
cells. Thus, expression of netrin-1 in plaques would be predicted to simultaneously prevent
inflammatory cell egress and induce smooth muscle cell recruitment into the intima, thereby
promoting lesion progression. In support of thishypothesis, we demonstrate that deletion of
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netrin-1 in myeloid cells severely reduced atherosclerosis lesion size and complexity in
Ldlr−/− mice and was associated with macrophage emigration from plaques.
RESULTS
Macrophage foam cells express the guidance cue netrin-1
Given its role in attenuating leukocyte migration18, we first investigated whether netrin-1 is
expressed in atherosclerotic plaques. Immunostaining of serial sections of human coronary
artery atherosclerotic plaques showed expression of netrin-1 and its chemorepulsive receptor
UNC5H2 (also called UNC5b) in lesional cells that express the macrophage marker HAM56
(Supplementary Fig 1a,b). By contrast, DCC, the chemoattractive netrin-1 receptor, was not
detected in these plaques (data not shown). A similar pattern of lesional netrin-1 staining
was seen in the Ldlr−/− mouse model of atherosclerosis (Fig. 1a). In aortic sinus plaques of
Ldlr−/− mice fed a western diet (WD) for 12 weeks, double staining for netrin-1 and the
macrophage marker CD68 showed netrin-1 expression by lesional macrophages. In addition,
extracellular netrin-1 staining was apparent in macrophage-rich regions of the plaque,
consistent with netrin-1 being a secreted protein that can bind to extracellular matrix
components. Analysis of the aortic arch, a second site of lesion predilection in mice, showed
that Ntn1 mRNA was increased in Ldlr−/− mice compared to wild-type C57BL/6 mice, and
netrin-1 expression was further upregulated by feeding these mice a WD (Fig. 1b). Similar
results were obtained in the Apoe−/− mouse model of atherosclerosis (Supplementary Fig.
1c), indicating that netrin-1 expression by lesional macrophages is a common characteristic
of mouse and human atheroma.
To understand the molecular mechanisms regulating netrin-1 and UNC5b expression, we
isolated peritoneal macrophages (pMø) from Ldlr−/− mice fed either a chow or WD. In this
commonly used model of in vivo foam cell formation, WD-feeding markedly increased
Ntn1 and Unc5b mRNAs, whereas expression of CD68 was unchanged (Fig. 1c). Similar
results were observed in hypercholesterolemic Apoe−/− mice (Supplementary Fig. 1d),
suggesting that increased cellular lipid accumulation may upregulate expression of netrin-1
and UNC5b. To test this, we treated pMø with native LDL, or LDL that had been oxidized
(oxLDL), a modification that promotes cholesterol loading of macrophages.
Consistent with our in vivo data, oxLDL, but not LDL, increased macrophage expression of
Ntn1 and Unc5b mRNA (Fig. 1d, Supplementary Fig. 1e). Immunoblot analysis confirmed
increased cell-associated netrin-1 protein in oxLDL-treated macrophages (Fig. 1e), which
was paralleled by an increase in netrin-1 in cell culture supernatants (Fig. 1f). Notably, the
induction of Ntn1 mRNA (Fig. 1g) and netrin-1 protein (Supplementary Fig. 1f) by oxLDL
required CD36, a scavenger receptor previously implicated in macrophage retention in
atherosclerotic plaques22. Because we and others have shown that oxLDL binding to CD36
induces NF-κB activation23,24 and the Ntn1 promoter contains an NF-κB binding site20, we
investigated whether NF-κB contributes to the upregulation of Ntn1. Using a Ntn1
promoter-luciferase reporter gene, we demonstrate that Ntn1 promoter activity was induced
by oxLDL and this was reduced by the NF-κB inhibitor BAY 11-7082 (Fig. 1h).
Collectively, these data demonstrate that loading of macrophages with cholesterol under
physiologic conditions, or by oxidized lipids via CD36 in vitro, increases expression of
netrin-1 and its receptor UNC5b.
Netrin-1 blocks the directed migration of macrophages
We next assessed the impact of netrin-1 on macrophage chemotaxis using transwell Boyden
chambers and a real-time detection method (xCelligence). Using both methods, recombinant
netrin-1 potently inhibited the chemotaxis of the macrophage cell line RAW264.7 to CCL2,
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also known as monocyte chemoattractant protein-1 (MCP-1), but had little effect on
macrophage migration in the absence of chemokine (Fig. 2a-b). The inhibitory effects of
netrin-1 on chemotaxis were dose dependent (Fig. 2a), with 250 ng/ml netrin-1 inhibiting
CCL2-induced migration by >90% (Fig. 2b). Furthermore, pre-treating RAW264.7 cells
with netrin-1 for 1 h rendered the cells refractory to CCL2 (Fig 2c). Similar to its effects on
RAW264.7 macrophages, netrin-1 potently inhibited chemotaxis of pMø to CCL2 (Fig 2d).
This effect was not chemokine-specific, as netrin-1 also blocked migration of RAW264.7
and pMø to the CCR7 ligands CCL19 and CCL21 (Fig 2e, Supplemental Fig. 2a-g),
chemokines implicated in the egress of CD68+ cells from plaques8,9. To gain insight into the
mechanisms by which netrin-1 inhibits macrophage chemotaxis, we measured its effect on
organization of the actin cytoskeleton. Stimulation of pMø with CCL2 or CCL19 induced a
marked reorganization of actin, characterized by the appearance of membrane ruffles,
lamellipodia and filapodia (Fig. 2f (arrows), Supplementary Fig. 3a), and rapid cell
spreading (Fig. 2g, Supplementary Fig. 3b). By contrast, pMø pre-treated withnetrin-1 prior
to stimulation with CCL2 or CCL19 maintained a rounded morphology (Fig. 2f
(arrowheads), Supplementary Fig. 3a) and showed no increase in mean cell area (Fig. 2g,
Supplementary Fig. 3b), consistent with a non-motile status. Quantification of phalloidin-
stained actin filaments by flow cytometry confirmed that netrin-1 blocked the increase in
polymerized actin-1 associated with CCL2 stimulation (Fig. 2h). As the Rho GTPase Rac1
plays a key role in the reorganization of actin in macrophages, we next investigated whether
netrin-1 altered Rac1 activation following chemotactic stimulation using glutathione-S-
transferase (GST) beads conjugated to the PAK1-PBD to detect the activated GTP-bound
form of Rac1. Whereas netrin-1 pretreatment of macrophages modestly increased basal
amounts of activated Rac1, it inhibited CCL2-induced Rac1 activation (Fig. 2i) and
phosphorylation of the focal adhesion kinase FAK (Fig. 2j), which cooperates with Rac1 to
link the actin cytoskeleton to the extracellular matrix during cell spreading and migration.
Collectively, these data indicate that netrin-1 inhibits the directional migration of
macrophages by disrupting the Rac1 signaling cascade, re-organization of the actin
cytoskeleton and cell polarization. As both netrin-1 and UNC5b were upregulated in
cholesterol-loaded macrophages we postulated that netrin-1 secreted by macrophages in
atherosclerotic plaques may act in an autocrine or paracrine manner via UNC5b to
immobilize these cells in the artery wall. To test the role of UNC5b in the response to
netrin-1, we pre-incubated macrophages with a recombinant UNC5b-Fc fusion protein or an
antibody that binds to the extracellular domain of UNC5b. Both the recombinant UNC5b-Fc
(Fig. 3a) and Unc5b antibody (Fig. 3b), but not control IgG, reversed the inhibitory effect of
netrin-1 on CCL19-induced migration. By contrast, no change was seen with an inhibitor of
the A2B adenosine receptor, another netrin-1 receptor implicated in the attenuation of
neutrophil migration (Fig. 3c). Furthermore, consistent with the secretion of netrin-1 by
macrophage foam cells, conditioned medium from oxLDL-but not LDL-treated
macrophages, inhibited cell migration to CCL19 (Fig. 3d), and this was reversed by
recombinant UNC5b-Fc (Fig. 3e). To confirm that netrin-1 is the active component secreted
by oxLDL-treated Mø, we used pMø isolated from Ntn1−/− bone marrow chimeric mice,
which do not express netrin-1 in response to oxLDL (Fig. 3f). Whereas conditioned medium
from oxLDL-treated Ntn1+/+ pMø inhibits migration of naïve macrophages to CCL19 by
80%, conditioned medium from similarly treated Ntn1−/− macrophages reduces migration by
only 25% (Fig. 3f). Furthermore, Ntn1+/+ conditioned medium incubated with recombinant
UNC5b-Fc inhibited migration to a similar extent as Ntn1−/− conditioned medium (≈25%).
By contrast, the effects of Ntn1−/− conditioned medium were unchanged by the addition of
recombinant UNC5b (Fig. 3f). Together, these data suggest that netrin-1 secreted by
cholesterol-laden macrophages would promote their accumulation in atherosclerotic plaques
by inhibiting their emigration from this site of inflammation.
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Studies in a transplant mouse model of atherosclerosis regression have demonstrated that
macrophages in plaques exit via nearby lymphatics upon aggressive cholesterol lowering6.
A similar pathway for macrophage clearance has been reported during resolving peritonitis
where inflammatory macrophages emigrate to the draining lymphatics of the omentum3,25.
To test the effect of netrin-1 on macrophage emigration in vivo we used a well-characterized
thioglycollate-induced peritonitis model in which administration of lipopolysaccharide
(LPS) induces the rapid egress of recruited leukocytes from the peritoneum22. As previously
reported, i.p. injection of LPS reduced the number of leukocytes in the peritoneum by 75%
in control mice (Fig. 3g). By contrast, mice pretreated with netrin-1 (i.p.) 45 min prior to this
inflammatory stimulus showed no significant change in peritoneal leukocytes. Flow
cytometric analysis of the macrophage marker F4/80 confirmed that macrophages were
retained in the peritoneum of netrin-1 pre-treated mice compared to control mice (0.4 × 106
± 0.1 × 106 control vs. 1.1 × 106 ±0.3 × 106 netrin-1). These data demonstrate that netrin-1
can inhibit the emigration of macrophages from a site of active inflammation.
Netrin-1 is a chemoattractant for smooth muscle cells
During the progression of atherosclerosis, smooth muscle cells from the underlying medial
layer are recruited to the plaque and participate in promoting plaque growth. To investigate
whether netrin-1 expression in plaque affects other cellular components of the
atherosclerotic lesion, we measured its effect on migration of human coronary artery smooth
muscle cells (CaSMCs). Unlike its inhibitory effect on macrophages, netrin-1 dose-
dependently induces migration of CaSMCs (Fig. 4a). Furthermore, conditioned medium
from oxLDL-, but not LDL-treated macrophages induces migration of CaSMCs (Fig. 4b).
To understand how Netrin-1 mediates chemoattraction of CaSMCs, we measured expression
of its known receptors. Whereas CaSMCs had low expression of Dcc and Unc5b, these cells
abundantly expressed the DCC-related receptor neogenin (Fig. 4c-d), as previously reported
for vascular smooth muscle cells13. Notably, pre-treatment of CaSMCs with a neogenin
antibody abrogated the chemoattractive effect of conditioned medium from oxLDL-treated
macrophages (Fig. 4e), supporting a role for foam cell derived netrin-1 in inducing SMC
migration. Immunohistochemical staining of atherosclerotic plaques of Ldlr−/− mice showed
colocalization of neogenin with smooth muscle actin (Fig. 4f), but not the macrophage
marker CD68 (Supplementary Fig. 4a). Furthermore, neogenin was expressed in medial
smooth muscle cells (arrows) and in smooth muscle cells that had migrated into the intima
(arrowheads), as well as some cells that were not smooth muscle actin positive (Fig. 4f).
Together these data indicate that through distinct mechanisms netrin-1 modulates CaSMC
and macrophages migration.
Hematopoietic deficiency of netrin-1 reduces atherosclerosis
Based on the above data we postulated that expression of netrin-1 by macrophage foam cells
may promote atherosclerotic plaque growth by both blocking macrophage egress and
inciting smooth muscle cell recruitment in the intima. To test this hypothesis, we used fetal
liver cells from day E14 Ntn1−/− or Ntn1+/+ (WT) pups to reconstitute the bone marrow of
lethally irradiated Ldlr−/− mice, thereby generating Ldlr−/− mice with either Ntn1−/− or WT
macrophages. Four weeks post-transplantation, the chimeric Ntn1−/− →Ldlr−/− and WT
→Ldlr−/− mice were challenged with a WD for 12 weeks. Analysis of Ntn1 and Ldlr gene
expression in both circulating leukocytes and pMø of recipient mice confirmed a complete
change in the genotype to the donor types (Supplementary Table 1, Supplementary Fig. 4b).
There were no differences in serum total cholesterol and triglyceride concentrations, or
cholesterol distribution in VLDL, LDL, and HDL in chimeric Ntn1−/− →Ldlr−/− and WT
→Ldlr−/− mice (Supplementary Table 1, Supplementary Fig. 4c). Despite these similar
serum cholesterol profiles, Ldlr−/− mice lacking expression of Ntn1 in bone marrow-derived
cells show a striking reduction in atherosclerosis (Fig. 5).
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Analysis of the aorta en face showed that Ntn1−/− →Ldlr−/− mice had a 55% reduction in
mean atherosclerotic lesion area compared to WT →Ldlr−/− mice (Fig 5a) that was present
throughout the aorta (Supplemental Fig. 4d). Isolation of mRNA from the aortic arch of the
Ntn1−/− →Ldlr−/− mice showed reduced expression of the macrophage marker CD68
compared to WT →Ldlr−/− mice (Fig. 5b), and correspondingly, lower expression of Ntn1
(Fig. 5c). Ntn1−/− →Ldlr−/− mice also had reduced expression of markers for other
leukocyte subsets in the aortic arch, including CD3 (T cell) and CD11c (dendritic cell) (Fig.
5b). Furthermore, analysis of atherosclerotic plaques in a second anatomical site, the aortic
root, showed markedly smaller lesion area in Ntn1−/− →Ldlr−/− mice compared to WT
→Ldlr−/− mice (Fig. 5d-f). Quantification of lesion burden by cross-sectional analysis of the
aortic root established that this decrease in lesion area in Ntn1−/− →Ldlr−/− mice was
consistently present throughout the 400 μm of the aortic root (Fig. 5e).
Histological characterization of the aortic sinus plaques using the Stary method revealed that
WT →Ldlr−/− mice had more advanced atherosclerosis, typified by a greater proportion of
complex lesions (stage 3-4), whereas Ntn1−/− →Ldlr−/− plaques tended to be less progressed
(stage 1-3) (Fig. 6a). Immunohistochemical staining of aortic sinus plaques confirmed a
reduction in both macrophage (MOMA-2, Fig. 6b) and smooth muscle cells (alpha smooth
muscle actin, Fig. 6c) in Ntn1−/− →Ldlr−/− compared to WT →Ldlr−/− mice. During the
progression of atherosclerosis, macrophage persistence contributes to changes in plaque
morphology, particularly the formation of the necrotic core. This critical feature of
dangerous plaques arises from the combination of apoptosis of cholesterol-laden
macrophages and defective phagocytic clearance of the apoptotic cells by the surrounding
macrophages (efferocytosis). Notably, TUNEL staining revealed that plaques in Ntn1−/−
→Ldlr−/− mice contained significantly fewer apoptotic cells compared to WT →Ldlr−/−
mice (Fig. 6d) and this correlated with a 46% decrease in necrotic area in Ntn1−/− →Ldlr−/−
plaques (Fig. 6e). Together these data suggest that netrin-1 expression by lesional
macrophages promotes atherosclerotic plaque growth and complexity by enhancing
macrophage retention in the intima.
To test whether netrin-1 expression in plaques inhibits macrophage emigration, we used a
macrophage tracking technique in which monocytes can be selectively labeled in vivo with
fluorescent beads so that their movement into26 and out of7 plaques can be tracked. WT
→Ldlr−/− and Ntn1−/− →Ldlr−/− mice were harvested 72 h after labeled bead injection, a
time point previously shown to have peak recruitment of labeled cells to atherosclerotic
plaque (“baseline”)26, and after 14 days to measure the number of labeled macrophages
remaining in plaques. The number of bead-labeled macrophages in WT →Ldlr−/− plaques
was similar at baseline and 14 days, indicating that macrophages did not emigrate during
this time (Fig. 6f). By contrast, in Ntn1−/− →Ldlr−/− plaques there was a 40% decrease in
beads after 14 days compared to baseline, indicating that fewer macrophages were retained
in the plaque in the absence of netrin-1. As the beads cannot be degraded, and any labeled
macrophages undergoing apoptosis are phagocytosed by surrounding macrophages thereby
transferring the bead label, the reduction in beads in the Ntn1−/− →Ldlr−/− mice was
indicative of macrophage movement out of the plaque. Collectively, our data support the
retention of macrophages in plaques by netrin-1 and demonstrate that upon the removal of
this retention signal, macrophages emigrate from this site of chronic inflammation.
DISCUSSION
It is appreciated that plaques that cause clinical events, so called “vulnerable plaques”, have
a high macrophage content2. Thus, strategies targeted at reducing macrophage accumulation
and/or directing emigration of these cells from the plaque offer promise as a complement to
standard lipid lowering therapies. However to date, the signals responsible for mediating
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macrophage retention in the artery wall have been poorly understood. Our data establish that
netrin-1, a neuronal guidance molecule with recently ascribed immunomodulatory functions,
and its receptor UNC5b, are expressed by macrophage foam cells of human and mouse
atherosclerotic plaques. Notably, recombinant netrin-1 and netrin-1 secreted by in vitro
formed foam cells potently block the directed migration of macrophages to CCL19, a
chemokine implicated in the emigration of monocyte-derived cells from plaques in a
transplant model of regression8,9. Moreover, netrin-1 also blocked migration of
macrophages to CCL2, which along with its receptor CCR2, has been shown to play roles in
myeloid cell trafficking to the lymph node during inflammation27,28. Thus, netrin-1 in
plaques may act to immobilize macrophage foam cells and prevent their egress to the lumen
or lymphatic system. Supporting this hypothesis, we find that the selective deletion of
netrin-1 in bone marrow derived cells markedly reduces atherosclerotic lesion size and
complexity in Ldlr−/− mice, and is associated with macrophage emigration from plaques.
These data establish a causative role for netrin-1 in the persistence of inflammation in
atherosclerosis, and highlight the importance of such negative regulators of leukocyte
migration in chronic inflammation.
There have been an increasing number of reports that guidance molecules characterized in
the developing nervous system can modulate leukocyte migration in inflammatory
states18,29-31. Such studies have shown that members of the netrin, slit, semaphorin and
ephrin families of guidance cues can have both chemoattractive and chemorepulsive effects
on leukocyte trafficking. Recent studies from our group and others have shown that netrin-1
is expressed on endothelial and epithelial cells, where it appears to function in limiting
leukocyte transmigration into tissues18-20,32. For example, endothelial expression of netrin-1
is downregulated in the lung during acute Staphylococcus aureus induced inflammation,
coincident with recruitment of neutrophils to the tissue18. By contrast, netrin-1 is
upregulated on gut epithelial cells during transient ischemia and attenuates neutrophil
recruitment to protect from hypoxia-induced inflammation20. These studies showing that
netrin-1 inhibits migration of circulating leukocytes into tissues, and thus is anti-
inflammatory in this capacity, have provided insight into the homeostatic barrier functions
performed by netrin-1. In this regard, a recent study reported that intravenous viral delivery
of netrin-1 to Ldlr−/− mice reduced atherosclerosis33, presumably by increasing its
expression on endothelial cells, although no determination of the cell types expressing
netrin-1 were made. Unfortunately, this study was underpowered and the traditional
atherosclerosis measurements of cross-sectional lesion area and en face aortic lesion burden
were not assessed, limiting its conclusions. By contrast, our data indicate that the expression
of netrin-1 by macrophage foam cells within plaques is pro-atherosclerotic, and its
inactivation of macrophage emigration from this inflamed site likely inhibits the resolution
of inflammation. Thus, as in the nervous system where netrin-1 can have both positive and
negative effects on axonal migration, it may play multifunctional roles in regulating
inflammation depending on the site of its expression.
While expressed at low levels in monocytes and most tissue macrophages, netrin-1 is highly
expressed by macrophage foam cells in human and mouse atheroma. The mechanisms of
netrin-1 upregulation in this context may be similar to those in hypoxia, where HIF1-α and
NF-κB regulate netrin-1 transcription19,20,34. Hypoxic stress is intimately linked to
atherosclerosis35 and these transcription factors are activated in lesional macrophage.
Induction of netrin-1 by oxLDL involved activation of NF-κB via CD3623,24, a scavenger
receptor previously implicated in the retention of macrophages in atherosclerosis22,36.
Macrophages that infiltrate the arterial intima are thought to exit via lymphatic vessels or
egress into the bloodstream, or undergo apopotosis and efferocytotic clearance37-39. All of
these mechanisms appear to be impaired in atherosclerosis, leading to the progressive
accumulation of macrophages in plaques. However, recent studies in mouse models suggest
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that these processes can be restored with aggressive lipid management, providing hope that
atherosclerosis regression can be achieved in humans40. Genetic manipulations that reduced
plasma non-HDL cholesterol and/or increased HDL cholesterol, promoted macrophage
emigration from plaques to regional and systemic lymph nodes via a mechanism involving
CCR7, the receptor for CCL19/CCL215-9. Notably, as netrin-1 blocked macrophage
chemotaxis to CCL19 and CCL21, it would be expected to inhibit the normal migratory
processes that bring about resolution of inflammation. Consistent with this, deletion of
netrin-1 in lesional macrophages in Ldlr−/− mice promotes macrophage emigration and
reduces plaque size. Although the exact means by which netrin-1 inhibits migration remains
to be elucidated, our data indicate that netrin-1 inhibits Rac-mediated re-organization of the
actin cyctoskeleton, preventing cell spreading and the migration of macrophages out of
plaques.
In addition to its effects on macrophages, netrin-1 is a potent chemoattractant for CaSMC, a
process dependent on the neogenin receptor. The recruitment of smooth cells by netrin-1
represents a second mechanism by which this guidance molecule could promote
atherosclerosis. During plaque progression, the internal elastic lamina can become breached
and smooth muscle cells migrate into the intima to participate in lesion growth. In plaques of
Ntn1−/− →Ldlr−/− chimeric mice, we see a reduction in the accumulation of smooth muscle
cells, consistent with the notion that loss of netrin-1 both allows macrophage emigration
from the plaque, and curtails the recruitment of SMC into it. Furthermore, Ntn1−/− →Ldlr−/−
plaques show fewer apoptotic cells and reduced necrotic area indicating that the mechanisms
regulating tissue homeostasis are enhanced in the absence of netrin-1. Together these data
underscore the important role that negative guidance cues may play in the persistence of
inflammation, and indicate that local inhibition of such factors may have therapeutic value
for the resolution of inflammation in atherosclerosis, and other chronic inflammatory
diseases.
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APPENDIX
METHODS
Mice
C57BL/6J, Ldlr−/− and Apoe−/− mice were from Charles River Laboratories or Jackson
Laboratories. Ntn1+/− mice were a kind gift from M. Tessier-Lavigne (Stanford University)
and were backcrossed 8 generations onto a C57BL/6 background. Cd36−/− mice were
generated in our laboratory41. All mice were maintained in a pathogen-free facility.
Experimental procedures were done in accordance with the USDA Animal Welfare Act and
the PHS Policy for the Human Care and Use of Laboratory Animals and the Massachusetts
General Hospital’s and New York University School of Medicine’s Subcommittees on
Research Animal Care and Use.
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Immunohistochemical staining
Human left anterior descending coronary artery segments were obtained from hearts excised
at the time of cardiac transplantation, then fixed in neutral buffered formalin and embedded
in paraffin. The use of human coronary artery tissue for these studies was approved by the
University of Washington Human Subjects Review Committee. Atherosclerotic plaque
morphology was determined from 6-μm sections stained with Movat’s pentachrome stains.
Macrophages were identified using monoclonal antibody HAM-56 (titer: 1:10,
DakoCytomation). Rabbit polyclonal antisera were used to identify netrin-1 (titer: 1:500,
Calbiochem) or UNC5b (generated by T. B. Kinane against an extracellular domain:
SQAGTDSGSEVLPDS)18 and normal rabbit serum was used as a negative control. Nova
red (Vector Laboratories), which yields a red reaction product, was used as the peroxidase
substrate and cell nuclei were counterstained with hematoxylin. Macrophages in mouse
atherosclerotic lesion were immunostained using rat anti-macrophage antibody (MOMA-2,
AbD Serotec), anti-rat HRP-conjugated antibody (AbD Serotec) or control rat IgG2b (AbD
Serotec) and DAB Substrate Kit (BD Pharmingen). To detect smooth muscle cells, anti-
smooth muscle actin (1A4, AbD Serotec) or mouse IgG2a (DakoCytomation) as a negative
control were used together with ARK™ animal research kit peroxidase (DakoCytomation)
according to manufacturer’s instructions. Cell nuclei were counterstained with hematoxylin
(Sigma-Aldrich).
Immunofluorescence staining
Human CaSMCs cultured on glass coverslips were fixed with ice-cold methanol for 4 min at
−20°C and blocked with 5% FBS in PBS for 20 min at 22°C. Thereafter, cells were
incubated with the indicated primary antibodies for 1 h at 22°C [goat-anti-human neogenin
(1 μg/ml, C-20, Santa Cruz Biotechnology), goat-anti-human DCC (4 μg/ml, A-20, Santa
Cruz Biotechnology), or normal goat IgG (Santa Cruz Biotechnology)], followed by
incubation with a donkey-anti-goat-IgG conjugated to Alexa 488 (Invitrogen). Cells were
mounted in Vectashield® mounting medium with DAPI (Vector Laboratories). Images were
taken on a Diaphot TMD inverted microscope (Nikon) with a 63x objective and appropriate
filters.
Cross-sections of the aortic roots from Ldlr−/− mice (5 μm) were fixed with 100% acetone
for 10 min and blocked with 4% BSA in PBS. Next, the sections were incubated with the
indicated primary antibodies for 2 h at 22°C or overnight at 4°C [rabbit-anti netrin-1 (0.3
μg/ml, ab26162, Abcam), rat-anti-mouse CD68 non-conjugated or conjugated to Alexa 488
(1:300, FA-11, AbD Serotec), rabbit-anti neogenin (1.6 μg/ml, ab26299, Abcam), goat-anti-
smooth muscle actin (2.5 μg/ml, ab21027, Abcam)]. Sections were washed and when
necessary incubated with biotinylated anti-rabbit-IgG (BA-1000, Vector Laboratories) for
30 min followed by incubation with strepavadin conjugated to Texas Red (Sa-5006, Vector
Laboratories), strepavadin conjugated to Fluorescein (Sa-5001, Vector Laboratories),
donkey-anti-goat IgG conjugated to Alexa 488 (Invitrogen) or goat-anti-rat IgG conjugated
to Alexa 568 (Invitrogen) for 15 min. Sections without primary antibody served as negative
controls. The sections were mounted using Vectashield medium with DAPI and visualized
using either TCS-SP confocal laser scanning microscope (Leica) or Axioscope 2 Plus
fluorescence microscope (Carl Zeiss).
Cell culture
RAW 264.7 and HEK293T cells were obtained from ATCC. Peritoneal macrophages were
collected from mice by peritoneal lavage 4 d after intraperitoneal injection with 3%
thioglycollate as previously described41. Cells were washed in PBS and used for migration
or cultured overnight in DMEM (10% FBS) and stimulated for 6-48 h in reduced serum
medium (2% FBS) with 50 μg/ml LDL (Biomedical Technologies Inc) or LDL oxidized as
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previously described42. RNA or protein was isolated as described42. Conditioned medium
from 4 × 106 cells were collected in 1 ml and concentrated to 250 μl using a centricon
YM-30 (Millipore). Human coronary artery smooth muscle cells (Cambrex Bio Sciences)
were cultured in growth factor supplemented SmBM.
RT-qPCR
RNA (0.5-1 μg) was reverse transcribed using iScript™ cDNA Synthesis Kit (Biorad)
according to manufacturer’s instruction. DNA from mouse blood was isolated using
ArchivePureTM DNA Kit (5Prime) according to manufacturer’s protocol. RT-PCR analysis
was conducted using iQ SYBR green Supermix (Biorad) or iTaq Supermix (Biorad) on the
iCycler Real-Time Detection System (Biorad). Fold change in mRNA expression was
calculated using the comparative cycle method (ΔΔCt). Sequences of primers used are
listed in Supplementary table 2.
Immunoblot analysis
Cells were washed in ice-cold PBS and lysed in ice cold RIPA buffer supplemented with 1
mM sodium orthovanadate, 1 mM phenylmethanesulfonylfluoride and 1 mg/ml protease
inhibitor cocktail (Roche). 50 μg of protein was separated on a SDS-PAGE gel, transferred
to a nitrocellulose or PVDF membrane and blocked in 5% BSA in Tris-buffered saline pH
7.2 containing 0.1% Tween-20 (TBS-T) for 2 hours at 22°C. The membranes were
incubated with 1 μg/ml polyclonal rat anti-mouse netrin-1 (158936, R&D Systems) or 0.1
μg/ml phospho-FAK (Tyr576/577, Cell Signaling) overnight at 4°C. Blots were incubated
with goat anti-rat horseradish peroxidase-conjugated secondary antibody (1:10,000 dilution,
Sigma-Aldrich) or goat anti-rabbit horseradish peroxidase-conjugated secondary antibody
(1:2000 dilution, Sigma-Aldrich) for 1 h at 22°C and exposed to ECL reagent (Amersham
Biosciences). Signal was recorded using Hyperfilm (Amersham Biosciences). After
chemiluminescence detection, memberanes were stripped with 0.2 M NAOH and reprobed
with antibodies against α-tubulin (B-5-1-2, Sigma-Aldrich) or FAK (77/FAK, BD
Biosciences) for normalization. Densitometry analysis of the gels was carried out using
ImageJ software from the NIH (http://rsbweb.nih.gov/ij/).
Netrin-1 ELISA
Detection of netrin-1 by ELISA was performed as previously described34, with minor
modifications. Briefly, 96-well plates (EIA/RIA plate, Corning Incorporated) were coated
with 500 ng/well recombinant UNC5b-Fc protein (R&D Systems). Before adding sample,
each well was incubated with 350 μl/well of blocking solution, containing 5% (w/v) BSA
(Fisher Scientific) in PBS. Standards made with recombinant netrin-1 protein or conditioned
medium (250 μl) were added to the coated plates and incubated for 16 h at 4°C plus 2 h at
37°C. After three washes with 0.5% BSA in PBS, 100 μl/well rat anti-netrin-1 (1 μg/ml in
0.5% BSA in PBS, 158936, R&D Systems) was added to each well and incubated for 30
min at 37°C. After extensive washing, each well was incubated with 100 μl/well HRP-
conjugated rabbit anti-rat (1:2000 in blocking solution, Sigma-Aldrich) for 30 min at 37°C.
After very extensive washing the plates were incubated for up to 20 min at 22°C with 200
μl/well peroxidase substrate solution, o-Phenylenediamine dihydrochloride
(SIGMAFAST™ OPD tablets, Sigma-Aldrich). The reaction was stopped with 50 μl/well
3M HCl and plate read at 492 nm using a multi-well plate reader (SPECTRAmax M5,
Molecular Devices).
Netrin-1 Promoter-Luciferase assay
HEK293T were transfected with a human Netrin-1 promoter luciferase reporter construct
(SwitchGear Genomics) using lipofectamineTM 2000 (Invitrogen). After transfection,
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media was changed and cells were pretreated with the NF-κB inhibitor BAY 11-7082 (20
μM) for 1 h prior stimulation with 100 μg/ml oxLDL or PBS as a control for 24 h.
Luciferase activity was assessed using the Dual-Glo Luciferase Assay System (Promega)
and normalized to a constitutively expressed Renilla reporter.
F-actin staining
Freshly isolated peritoneal macrophages were seeded on 8-well LabTek slides (Thermo
Scientigfic) for 24 h or used directly. The cells were pretreatment with mouse recombinant
netrin-1 (250 ng/ml, R&D Systems) or PBS for 30 min and stimulated with either CCL19
(500 ng/ml, R&D Systems) or CCL2 (10 ng/ml R&D systems) for the indicated times.
Macrophages were fixed (4% paraformaldehyde), permeabilized (0.1% Triton X-100) and
actin filaments stained with Alexa Fluor 568 or 647 phalloidin (Molecular probes,
Invitrogen) at a dilution of 1/40. Cells in suspension were analyzed by flow cytometry (C6
Flow Cytometer, Accuri Cytometers, BD Biosciences). The cells on coverslips were
mounted after DAPI staining and vizualized with a Nikon Eclipse microscope and images
were captured using the NIS-elements software. Images were background corrected
followed by measurement of the average cell area of at least 10 cells per field using the
Ivision software.
Rac1 activation assays
Peritoneal macrophages were seeded in a 6-well plate overnight in regular growth media.
The cells were stimulated with CCL2 (10 ng/ml R&D systems) for 5 min with or without a
pretreatment with mouse recombinant netrin-1 (250 ng/ml, R&D Systems) for 30 min. At
the end of stimulation the cells were lysed and Rac1-GTP was measured using Rac1
Activation Assay (Cell Biolabs) according manufacturer’s instructions.
Migration assays
Chemotaxis of macrophages (pMø, RAW264.7) and CaSMC was measured in 96-well
Boyden chamber with a 5 μm (macrophages) or 8 μm pore size filter (CaSMC) (Neuro
Probe) as previously described18. Macrophage chemotaxis was also quantified using a Real-
time Cell Invasion and Migration (RT-CIM) xCelligence assay system with monitoring
every 5 min (Roche Applied Science). Cell migration to CCL2 (100 ng/ml; R&D Systems)
or CCL19 (500 ng/ml; R&D Systems) was measured in the absence or presence of
recombinant netrin-1 (mouse or chicken from R&D Systems), recombinant rat UNC5b-Fc
chimera (cat# 1006-UN, R&D Systems) or whole IgG (Jackson Lab) or conditioned medium
from LDL- or oxLDL-stimulated pMø. In some assays, cells were pretreated netrin-1 or
UNC5b blocking antibody (AF1006, R&D Systems) or Neogenin blocking antibody (Santa
Cruz, sc- 6537) or control goat IgG (Santa Cruz) for 1 h prior to migration. Following cell
migration for 3 or 16 h (CaSMC and macrophages, respectively), 4 random high power
fields from each well were counted to determine the number of cells that had migrated into
the lower chamber. Migration was expressed as chemotactic index, which was calculated by
dividing the number of migrating cells in the treated groups by the number of migrating cells
in the lowest control well. Results of chemotaxis assays are representative of at least three
independent experiments performed on triplicate samples.
In vivo studies of inflammatory leukocyte emigration from the peritoneum
As previously described22,43, mice (n = 6/group) were injected intraperitoneally with 1 ml of
3% thioglycollate to incite a sterile peritonitis with macrophage numbers peaking on day 4.
After 4 d, the mice were pre-treated with netrin-1 (500 ng i.p.) or PBS for 45 min, and then
injected with an inflammatory stimulus (400 ng LPS) to induce efflux of leukocytes from
the peritoneum to the draining lymph nodes. After 3 h the peritoneal cells were collected by
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lavage and counted. The percentage of macrophages in the lavage was quantified by flow
cytometry using PE-conjugated anti-F4/80 (CI:A3-1, AbD Serotec).
Fetal liver cell transplantation
Female and male Ntn1+/− mice were mated. On day 14 of gestation, embryos were dissected
free from the placenta and yolk sac, and a single-cell suspension of fetal liver cell (FLC) was
prepared by flushing through graded sizes of needles. Part of the fetal tissues was used for
genotyping by X-gal staining intensity, the other part to provide independent confirmation of
the genotype by PCR analysis. FLC (2 × 106) were i.v. injected in lethally irradiated Ldlr−/−
mice, by 2 exposures of 600 cGy. 4 weeks after transplantation, mice were put on a western
diet (Teklad Adjusted Calories 88137; 21% (w/w) fat; 0.15% (w/w) cholesterol; 19.5% (w/
w) casein, no sodium cholate) for 12 weeks prior to atherosclerosis analysis.
Lipoprotein profile analysis
Pooled plasma from 3 mice per genotype was used to obtain lipoprotein profiles. Profiles
were obtained using FLPC gel filtration and Superose 6 column (Amersham Pharmacia),
fractions were analyzed for total cholesterol.
Atherosclerotic analysis
After 12 weeks of WD feeding, mice were anesthetized with Tribomoethanol (0.4mg/g i.p.)
and ex-sanguinated by cardiac puncture. Plasma was collected from fasted mice and total
plasma cholesterol and triglyceride concentrations were measured as described44. Aortas
were flushed with PBS and perfused with 10% neutral buffered formalin. Aortic roots were
embedded in OCT medium, and the aortic arch and descending aorta were placed in
formalin overnight. En face lesion analysis was performed on dissected aortas pinned open
and imaged with a dissecting microscope. Lesion area was quantified using IP Lab Spectrum
software version 3.9 (Scanalytics) and expressed as a percentage of the total aortic area or
defined regions. For cross-sectional analysis of lesion area in the aortic root, every second
section (5 μm thick) throughout the aortic sinus (400 μm) was taken for analysis and
quantified using IP Lab Spectrum software. Lesional necrotic areas were analyzed as we
previously described45, from the average of 6 hematoxylin and eosin stained sections (5 μm
thick) per mouse, spaced 25 μm apart. The necrotic area was defined as acellular and
anuclear white area and quantified using IP Lab Spectrum software45. Apoptotic cells were
labeled after proteinase K treatment by TUNEL (TdT-mediated dUTP nick-end labeling)
using the in situ cell death detection kit TMR-red (Roche Diagnostics). TUNEL and DAPI
staining was viewed using an Zeiss Axioplan Inverted fluorescent microscope and only
TUNEL-positive cells that colocalized with DAPI-stained nuclei were counted as being
positive.
Labeling and tracking of blood monocytes
Circulating blood monocytes of WT →Ldlr−/− and Ntn1−/− →Ldlr−/− chimeric mice were
labeled in vivo by retro-orbital i.v. injection of 1 μm Fluoresbrite green fluorescent (YG)
plain microspheres (Polysciences) diluted 1:4 in sterile PBS as previously described by us
and others7,8,26. This method predominantly labels Ly6clo monocytes and labeling
efficiency (% beads positive blood monocytes) was measured by flow cytometry 1 d after
injection of beads. One group of mice was harvested after 72 h for baseline measurements,
as this time point has previously been shown to have optimal recruitment of labeled
monocytes to atherosclerotic plaques and clearance of the labeled monocytes from the
blood. A second group of mice was harvested 14 d later to measure the number of labeled
macrophages remaining in plaques. The number of beads per section were normalized for
the monocyte labeling efficiency by multiplying the mean number of beads per section of
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mouse A by the % bead positive blood monocytes of all mice/mouse A as previously
described. Over time, the bead content of the plaque will decrease if the beads left in the
same cells that brought them in or if they were transferred to another monocyte-derived cell
that then left. In other words, a decrease in bead number indicates that there was emigration
of monocyte-derived cells from the plaque.
Statistics
The difference between two groups was analyzed by Student’s t-test or by one-way ANOVA
followed by the Newman-Keuls multiple comparison test. A P-value of <0.05 was
considered significant.
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Figure 1. Netrin-1 and it receptor UNC5b are abundantly expressed by macrophage foam cells
in atherosclerotic lesions
(a) Immunofluorescent staining of netrin-1 (green) and CD68 (red), and their colocalization
(yellow, arrows), in aortic sinus atherosclerotic plaques of Ldlr−/− mice fed a WD. Dashed
line indicates lesion border (scale bar= 50 μm). Staining is representative of plaques from 4
mice. (b) qPCR analysis of Ntn1 mRNA isolated from the aortic arch of C57BL/6 or Ldlr−/−
mice fed a chow or WD. (c) qPCR analysis of Ntn1, Unc5b, Cd68 and Abca1 mRNA in
pMø isolated from Ldlr−/− mice fed a chow or WD. (d) qPCR analysis of Ntn1 and Unc5b in
pMø treated with 50 μg/ml oxLDL, and corresponding expression of netrin-1 protein
measured in (e) cell lysates by immunoblot or (f) conditioned media by ELISA. (g) qPCR
analysis of Ntn1 mRNA in wild-type (WT) or Cd36−/− pMø stimulated with 50 μg/ml
oxLDL for 6 h. (h) Ntn1 promoter-luciferase reporter activity in HEK293 cells treated with
oxLDL in the presence or absence of the NF-κB inhibitor BAY 11-7082 (20 μM). (b-h)
Data are mean ± s.d. of triplicate samples in a single experiment and are representative of 3
independent experiments. *P<0.05.
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Figure 2. Netrin-1 inhibits macrophage migration to CCL2 and CCL19, via its receptor UNC5b
(a) Migration of RAW264.7 cells to CCL2 (100 ng/ml) was measured in the absence or
presence of increasing concentrations of recombinant netrin-1 placed in the lower
compartment of a Boyden chamber. (b) Real-time measurement of migration of RAW264.7
cells to 250 ng/ml netrin-1, 100 ng/ml CCL2, or both. (c) Migration of RAW264.7 cells
pretreated (PT) with 250 ng/ml netrin-1 and exposured to CCL2 (100 ng/ml). (d-e)
Migration of mouse pMø to (d) CCL2 (100 ng/ml) or (e) CCL19 (500 ng/ml), in the
absence/presence of 250 ng/ml netrin-1. (f) pMø stained with phalloidin to detect
polymerized actin after treatment with 100 ng/ml CCL2 with or without 250 ng/ml netrin-1.
Arrows indicate membrane ruffles, scale bar 10 μm. (g) Mean cell surface area of pMø in
(f). (h). Quantification of actin polymerization by flow cytometric analysis of phallodin
staining. (i) Amount of activated Rac1 in pMø treated for 5 min with 100 ng/ml CCL2 with
and without 250 ng/ml netrin-1. (j) Immunoblot of phospho- and total FAK in pMø
incubated with 100 ng/ml CCL2 with or without 250 ng/ml netrin-1 pretreatment. Data are
the mean ± s.d. of triplicate samples in a single experiment and are representative of 3
independent experiments. P < 0.05, **P < 0.01.
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Figure 3. Foam cell secreted netrin-1 blocks macrophage migration
(a-c) Migration of pMø to CCL19 (500 ng/ml) with/without netrin-1 (250 ng/ml) in the
presence of (a) recombinant UNC5b-Fc or IgG control, (b) anti-UNC5b or isotype-matched
control antibody, or (c) an inhibitor of the A2B adenosine receptor (10 uM 8-PT). (d-e)
Migration of pMø to CCL19 (500 ng/ml) in (d) the presence or absence of conditioned
medium (CM) from macrophages treated with LDL or oxLDL (50 μg/ml; 48 h) and (e)
with/without recombinant UNC5b-Fc or IgG control. (f) Migration of pMø to CCL19 (500
ng/ml) as in (e) except using conditioned medium (CM) from WT or Ntn1−/− macrophages
treated with oxLDL. Inset: immunoblot of netrin-1 in lysates of WT and Ntn1−/− pMø. (a-f)
Data are the mean ± s.d. of triplicate samples in a single experiment and are representative
of 3 independent experiments. *P < 0.01. (g) Effect of netrin-1 (500ng) or PBS pretreatment
on LPS-induced leukocyte emigration from the peritoneum of mice with established
thioglycollate-induced peritonitis. Data are the mean number (± s.e.m) of leukocytes in the
peritoneum of mice (n = 6/group) before and 4h after injection of 400ng LPS ip., and are
representative of 2 independent experiments. *P < 0.05.
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Figure 4. Netrin-1 acts as a chemoattractant for smooth muscle cells via the receptor neogenin
(a) Migration of human CaSMCs in the presence of recombinant netrin-1. (b) Migration of
CaSMCs in the presence of conditioned media from macrophages treated for the indicated
times with LDL or oxLDL (50 μg/ml). (c) qPCR analysis of Neogenin, Unc5b and Dcc
mRNAs in CaSMC. (d) Immunofluorescent staining for neogenin, DCC or isotype-matched
control antibody in CaSMCs. Cells were co-stained with DAPI nuclear stain. Scale bar, 10
μm. (e) Migration of CaSMCs pre-treated with neogenin or isotype control antibody prior to
exposure to conditioned media from macrophages treated as indicated for 24 h. (f)
Immunofluorescent staining of alpha smooth muscle actin (SMA, green), neogenin (red) and
DAPI (blue) in atherosclerotic plaques of Ldlr−/− mice fed a WD. Co-localization of SMA
and neogenin (yellow in the merged image) was detected in the media (arrows) and in SMC
that had invaded the intima (arrowheads). Staining is representative of plaques from 5 mice.
Scale bar, 50 μm. (a-c, e) Data are the mean ± s.d. of triplicate samples in a single
experiment and are representative of 3 independent experiments. *P < 0.05.
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Figure 5. Targeted deletion of netrin-1 in immune cells reduces atherosclerosis burden
(a) Quantification and representative photographs of atherosclerosis in the aorta en face of
WT →Ldlr−/− and Ntn1−/− →Ldlr−/− chimeric mice (n=10/group). *P < 0.01. Scale bar, 5
mm. (b-c) qPCR analysis of Cd68 (macrophage), Cd3 (T cell), Cd11c (dendritic cell), Elane
(neutrophil) and Ntn1 mRNA in the aortic arches of WT →Ldlr−/− and Ntn1−/− →Ldlr−/−
chimeric mice (n=3/group). Data are the mean ± s.d. of triplicate samples in a single
experiment and are representative of 2 independent experiments. *P < 0.05. (d-e) Lesion
area of atherosclerotic plaques of the aortic root of WT →Ldlr−/− and Ntn1−/− →Ldlr−/−
mice expressed as the mean (d) of individual mice and (e) of each genotype across the 400
μm of the aortic root. *P < 0.005. (f) Representative photographs of hematoxylin and eosin
stained aortic sinus lesions of WT →Ldlr−/− and Ntn1−/− →Ldlr−/− mice. Scale bar, 200
μm.
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Figure 6. Targeted deletion of netrin-1 in immune cells reduces plaque complexity and promotes
macrophage emigration
(a) Classification of aortic sinus plaques of WT →Ldlr−/− and Ntn1−/− →Ldlr−/− mice (n =
10) according to the Stary method. I. Early (foam cells), II. Moderate 1 (foam cells, SMC),
III. Moderate 2 (foam cells, SMC, clefts), IV. Advanced (necrotic core). (b,c)
Immunohistochemical staining of aortic sinus plaques for (b) macrophages (MOMA-2) and
(c) SMC (α-smooth muscle actin). Scale bar, 100 μm. Staining quantified using IP Lab
Spectrum software is presented at right. n = 6-9. (d) Immunofluorescent staining of
apoptotic cells (green) in aortic sinus plaques. TUNEL positive nuclei are indicated by
arrowheads TUNEL and quantification is presented at right. Scale bar, 50 μm. n = 9. (e)
Quantification of necrotic areas of aortic sinus plaques. n = 10. *P = 0.07. (f) In vivo
analysis of macrophage recruitment and retention in atherosclerotic plaques of WT
→Ldlr−/− and Ntn1−/− →Ldlr−/−mice using a monocyte bead-tracking model. The mean
number of bead-labeled macrophages per plaque is shown 3 days (baseline) and 14 days
after monocyte labeling (n = 3-4/group). . Representative image of plaques stained for CD68
(red) and cell nuclei (blue). Arrows indicate the presence of the cells containing fluorescent
beads (green) within the lesion. Data in a-f are the mean ± s.e.m., *P < 0.05, unless
otherwise noted.
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